<DOC>
	<DOCNO>NCT02297360</DOCNO>
	<brief_summary>The Viviscal Extra-Strength formulation oral food/dietary supplement specifically design promote hair growth woman suffer temporary thin hair . It contain hormone drug market Europe 15 year . Viviscal Extra-Strength market Viviscal Maximum Strength territory . The hypothesis clinical research study ingestion Viviscal Extra-Strength three ( 3 ) month period strengthen promote growth terminal hair female subject , age 21-65 year age self-perceived thin hair associate poor diet , stress , hormonal influence abnormal menstrual cycle compare use placebo tablet .</brief_summary>
	<brief_title>Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair</brief_title>
	<detailed_description>The key ingredient Viviscal Extra-Strength formulation AminoMar C™ marine complex , Equisetum arvense sp . ( horsetail ) , contain naturally occur form silica ) , Malpighia glabra ( acerola cherry ) contain Vitamin C , Biotin Zinc . The AminoMar C™ active ingredient trademark comprises proprietary blend shark powder mollusc powder . It derive sustainable marine source . Viviscal provide essential nutrient nourish hair naturally within . Viviscal work many way several month use improve appearance thin hair . - Nourishes hair follicle - Strengthens promotes growth terminal hair . Terminal hair define coarse hair , short long , find scalp minimum cross-sectional diameter 40 micrometer . Vellus hair define fine , short hair find scalp maximum cross-sectional diameter 40 micrometer . - Supports growth hair slow temporarily stop - Hair become strong , healthier vibrant Ingestion Viviscal Extra-Strength three ( 3 ) month period strengthen promote growth terminal hair female subject , age 21-65 year age self-perceived thin hair associate poor diet , stress , hormonal influence abnormal menstrual cycle compare use placebo tablet . The primary endpoint individual hair count favorable analysis use Nikon CoolPix 4300 3GEN Dermlite Foto37 phototrichogram analysis end three ( 3 ) month period . The secondary endpoint statistically significant decreased hair shed count hair wash , favorable improvement terminal hair diameter measure Dino-Lite Digital Microscopic positive feedback Quality Life Self-Assessment questionnaire three ( 3 ) month Viviscal Extra-Strength ingestion . All patient enrol must identifiable throughout study . The Investigator maintain personal list patient number patient name enable record find later date list store locked cabinet . Subject number consist 2 digit number 01 60 . Patients randomize active placebo supplement ( 1:1 ratio ) use randomization table prepared prior start study non-participating staff member office Investigator . The study blind broken end study . All test product placebo label subject number per non-participating staff member . Subjects assign subject number numerical order enrol . Randomization occur assignment either Viviscal Extra-Strength supplement placebo 1:1 ratio . Subjects terminate study participation reason , regardless whether study medication use , retain randomization number . Visit Procedures Pre-Study Procedures 1 . Candidate subject screen eligibility requirement telephone prior Visit 1 . 2 . Candidate subject assign appointment time visit clinic . Visit 1 : Baseline , Day 0 1 . Individuals give informed consent ( IC ) document &amp; photographic release form , HIPAA form , confidentiality agreement read . They study related question answer Investigator designate staff agree , sign two copy IC/Photography release form , two copy HIPAA form , one copy confidentiality agreement . Subjects give one copy sign IC/Photography release HIPAA agreement keep , one copy document remain test facility subject 's file . 2 . Investigator and/or Study Coordinator review subject complete checklist inclusion exclusion criterion . 3 . Investigator and/or Study Coordinator review subject complete checklist medical history concomitant medication . 4 . Investigator and/or Study Coordinator review subject complete General Lifestyle Questionnaire . The General Lifestyle Questionnaire may find Appendix V. 5 . Subjects give Quality Life Questionnaire read complete . The Quality Life Questionnaire may find Appendix VI . 6 . Candidate subject receive brief physical exam , include examination scalp , rule immediately observable medical issue scalp alopecias/scalp disorder unacceptable qualification . The physical additionally include vital sign ( pulse blood pressure ) , weight height . 7 . Candidate subject childbearing potential complete urine pregnancy test prior product distribution . 8 . Candidate subject complete initial paperwork meet inclusion/exclusion qualification ( include finding physical exam ) assign unique subject number . Subjects randomize treatment group prior dispense test product . 9 . Qualified subject scalp prepared digital photography initial measurement do ( see Appendix I ) . 10 . Subjects select test site photograph ( see Appendix I II ) . 11 . Subjects ten ( 10 ) terminal hair select test site cut base scalp diameter hair measure ( see Appendix III ) . 12 . Subjects instructed wash hair home 24 hour advance study visit . Subjects hair wash ( shampooed ) Viviscal Gentle Shampoo sink contain cheesecloth ( see Appendix IV ) . The cheesecloth position collect shed hair . The number hair collect cheesecloth count record . Subjects allow dry style hair . 13 . Subjects dispense three ( 3 ) month supply test product ( three unit Viviscal Extra-Strength Placebo , randomize , contain 60 tablet ) give write verbal Usage Lifestyle instruction ( see Appendix VIII ) calendar future visit . Subjects instructed ingest test product per Sponsor instruction . Usage Instructions : Take two ( 2 ) tablet day , one morning one evening ; take water , food . Subjects instructed return empty packet unused test product Visit 2 . Lifestyle Instructions : Subjects instruct maintain normal hair care routine . Subjects instruct use brand/type hair care product maintain haircut , color style study duration . Subjects color treat hair also instruct color treatment perform time interval prior visit ( ie . If Visit 1 , color treatment do one week prior color treatment expect occur similar interval one week prior Visit 2 ) . Subjects instruct come visit clean ( shampoo must do 24 hour prior visit ) dry hair . Subjects instruct use medically sound form birth control study . Visit 2 : Month 3 ( 90 day ) ± 1 week ( 7 day ) 1 . A clinician ask subject experience change health take new/adjusted current medication since last visit . If AE SAE report , examine Investigator informed appropriate form complete . 2 . The test product collect counted compliance . 3 . Subjects receive brief physical exam . The physical include vital sign ( pulse blood pressure ) . 4 . Subjects complete Quality Life Questionnaire Self-Assessment Questionnaire ( see Appendix VI VII ) . 5 . Subjects scalp prepared digital photography ( see Appendix I ) . 6 . Subjects select test site photograph ( see Appendix I II ) . 7 . Subjects ten ( 10 ) terminal hair select test site cut base scalp diameter hair measure ( see Appendix III ) . 8 . Subjects instructed wash hair home 24 hour advance study visit . Subjects hair wash ( shampooed ) Viviscal Gentle Shampoo sink contain cheesecloth ( see Appendix IV ) . The cheesecloth position collect shed hair . The number hair collect cheesecloth count record . Subjects allow dry style hair . All primary secondary parameter collect Visits 1 2 . Missing data value minimize intensive training interviewer techniques clarify answer check questionnaire participant on-site . When miss value identify , several approach reschedule within 24 hour completion test interview employ acquire necessary data . Missing data also examine assess randomness . Descriptive statistic obtain variable , test normality continuous measure make data examine homogeneity variance . An appropriate statistical method employ correct abnormality . All statistical test two-tailed . Differences consider statistically significant provide p-value 0.05 less obtain p-values may evaluate case-by-case basis . For visit , difference two group baseline Visit test use analysis variance repeat measurement .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Hypotrichosis</mesh_term>
	<criteria>1 . Females , age 2165 year age 2 . Clinicallydetermined general good health determine response initial study assessment 3 . Females selfperceived thin hair associate poor diet , stress , hormone influence abnormal menstrual cycle determine initial study assessment Investigator ( This include patient medically diagnose telogen effluvium ) 4 . Females willing maintain normal hair shampoo frequency 5 . Females willing add provide oral supplement current daily routine 6 . Females willing substantially change current diet , medication , exercise routine duration study . If subject receives physician guidance study change diet , medication , exercise routine , subject need notify clinic soon possible 7 . Females willing undergo brief physical exam include height , weight , blood pressure , pulse , general physical finding scalp exam . The physical exam occur Visits 1 2 8 . Females Fitzpatrick IIV photo skin type 9 . Willingness digital photography target area scalp hair count Visits 1 2 10 . Willingness ten ( 10 ) terminal hair target area cut base scalp microscopic hair measurement Visits 1 2 11 . Willingness hair wash ( shampooed ) Viviscal Gentle Shampoo sink contain cheesecloth hair shed count Visits 1 2 12 . Willingness maintain consistent hair cut hair color throughout 3 month study period come visit clean ( shampoo must do 24 hour prior visit ) dry hair 13 . Willingness subject color treat hair color treatment perform time interval prior visit ( ie . If Visit 1 color treatment do one week prior color treatment expect occur similar interval one week prior Visit 2 ) 1 . Females know history intolerance allergy fish , seafood/shellfish acerola 2 . Females know allergy sensitivity shampoo/conditioner 3 . Females nurse , pregnant , plan become pregnant study 4 . Females know stressful incident within last six month ( ie . death family , miscarriage ) 5 . Females participate clinical research study ASIRC another research center doctor 's office 6 . Females recently ( within last 6 month ) start use hormone birth control hormone replacement therapy ( HRT ) . Women currently use hormone birth control HRT must stable dose ( 6 month longer ) order eligible study 7 . Females currently use HairMax light treatment light therapy treat thin hair 8 . Females regularly use Rogaine ( Minoxidil ) within last 3 month 9 . Females use prescription drug know affect hair growth cycle within last 6 month ( e.g. , hormonebased birth control le 6 month , cyproterone acetate , aldactone/spironolactone , Finasteride 5alphareductase inhibitor ) 10 . Females suffer hair loss disorder , alopecia areata , scar alopecia , androgenetic alopecia telogen effluvium determine initial study assessment Investigator 11 . Individuals selfreported uncontrolled disease ( i.e . diabetes , hypertension , hyperthyroidism , hypothyroidism , etc. ) . Medical condition control without treatment consider individual basis Investigators 12 . Females selfreported active hepatitis , immune deficiency , HIV autoimmune disease 13 . Females know active dermatologic condition , opinion examine Investigators , might place subject great risk interfere clinical evaluation ( e.g. , seborrheic dermatitis , psoriasis , atopic dermatitis , advanced skin cancer , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Hair loss , hair thinning , woman , marine protein supplement</keyword>
</DOC>